Prediction of the Pharmacokinetics of Atorvastatin, Cerivastatin, and Indomethacin Using Kinetic Models Applied to Isolated Rat Hepatocytes

Chapter 4 Preparation of Isolated Rat Liver Cells

1976 • 5,335 citations

A physiological approach to hepatic drug clearance

1975 • 1,855 citations

The Liver: Biology and Pathobiology.

1983 • 1,628 citations

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

1994 • 865 citations

Clearance concepts in pharmacokinetics

1973 • 741 citations

The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical Properties

2002 • 378 citations

A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES

2005 • 356 citations

FACTORS AFFECTING DRUG METABOLISM

1971 • 342 citations

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

2004 • 333 citations

Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.

2001 • 309 citations

Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver Slices

1997 • 298 citations

Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential

1999 • 295 citations

EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE

2004 • 264 citations

Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches

2005 • 246 citations

Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes

2004 • 219 citations

Physiologic modeling of cyclosporin kinetics in rat and man

1991 • 175 citations

THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES

2004 • 160 citations

Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo

2007 • 141 citations

Multiple Transporters Affect the Disposition of Atorvastatin and Its Two Active Hydroxy Metabolites: Application of in Vitro and ex Situ Systems

2005 • 141 citations

Development of a Novel in Vitro Model to Predict Hepatic Clearance Using Fresh, Cryopreserved, and Sandwich-Cultured Hepatocytes

2002 • 129 citations

The Impact of In Vitro Binding on In Vitro - In Vivo Extrapolations, Projections of Metabolic Clearance and Clinical Drug-Drug Interactions

2006 • 111 citations

PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM

2006 • 108 citations

Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes

2007 • 106 citations

Drug Metabolizing Enzymes

2003 • 95 citations

THE ROLES OF TRANSPORTERS AND ENZYMES IN HEPATIC DRUG PROCESSING

2004 • 93 citations

Organ clearance concepts: new perspectives on old principles.

1997 • 84 citations

APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA

2005 • 66 citations

In vitro–in vivoextrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspects

2007 • 63 citations

Effect of diffusional barriers on drug and metabolite kinetics.

1987 • 57 citations

Uptake and Intracellular Binding of Lipophilic Amine Drugs by Isolated Rat Hepatocytes and Implications for Prediction of in Vivo Metabolic Clearance

2006 • 55 citations

Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat.

1991 • 52 citations

Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution.

2001 • 45 citations

Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations.

1991 • 43 citations

Hepatobiliary Disposition of the Metabolically Stable Opioid Peptide [d-Pen², d-Pen⁵]-Enkephalin (DPDPE): Pharmacokinetic Consequences of the Interplay between Multiple Transport Systems

2004 • 39 citations

IN VITRO AND IN VIVO CORRELATION OF THE INHIBITORY EFFECT OF CYCLOSPORIN A ON THE TRANSPORTER-MEDIATED HEPATIC UPTAKE OF CERIVASTATIN IN RATS

2004 • 36 citations

Hepatobiliary Disposition of a Drug/Metabolite Pair: Comprehensive Pharmacokinetic Modeling in Sandwich-Cultured Rat Hepatocytes

2006 • 33 citations

Typical and Atypical Enzyme Kinetics

2003 • 30 citations

In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspects

2007 • 30 citations

MEMBRANE TRANSPORT AS A DETERMINANT OF THE HEPATIC ELIMINATION OF DRUGS AND METABOLITES

1996 • 29 citations

Evidence for a saturable, energy-dependent and carrier-mediated uptake of oral antidiabetics into rat hepatocytes

1992 • 28 citations

Fraction Unbound in Interstitial Fluid

1983 • 22 citations

Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids.

2003 • 21 citations

Typical and atypical enzyme kinetics, in Drug metabolism enzymes: Cytochrome P450 and other enzymes in drug discovery and development.

2003 • 10 citations

Determination of the rate-limiting step in the hepatic elimination of YM796 by isolated rat hepatocytes.

1999 • 9 citations